甲基酸诱导的肠损伤和保护策略背后的分子机制
Gaber F Ali1, Emad H M Hassanein2, Wafaa R Mohamed3
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni Suef, 62514, Egypt.
甲基 (MTX) 通过氧化应激和炎症引起肠道损伤. 了解这些氧化还原机制和探索保护剂可以帮助缓解MTX诱导的肠损伤.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 胃肠病学 胃肠病学
背景情况:
- 甲基 (MTX) 是治疗癌症和炎症疾病的重要药物.
- MTX的毒性,特别是肠道粘膜炎,对患者产生重大影响.
- 由MTX引起的肠损伤的确切机制需要进一步阐明.
研究的目的:
- 审查MTX诱导的肠损伤背后的氧化还原分子机制.
- 探索潜在的治疗剂和缓解MTX诱导的肠损伤的途径.
主要方法:
- 对MTX诱导的肠道毒性现有文献的综述.
- 分子通路的分析,包括氧化应激,炎症,NF-κB,JAK/STAT3和Nrf2/HO-1.
- 识别具有对MTX诱导的肠损伤潜在保护作用的药物.
主要成果:
- 由MTX引起的肠损伤涉及氧化应激和炎症反应.
- 涉及的关键途径包括NF-κB和JAK/STAT3激活.
- Nrf2/HO-1通路在抵消MTX诱导的氧化应激方面发挥着至关重要的作用.
结论:
- 了解氧化还原分子机制是管理MTX肠道毒性的关键.
- 几种药物在保护MTX诱导的肠损伤方面表现有前途.
- 针对这些途径可能会导致MTX相关的胃肠道并发症的新疗法策略.
更多相关视频
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
